Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...

Maya Ajmera, President & CEO of the Society for Science and Executive Publisher of Science News, spoke with David R. Liu, Thomas Dudley Cabot Professor of ...

Explore Twist Bioscience (NASDAQ:TWST) developments, Nasdaq Today trends, and impact on Healthcare Stocks and biotech ...

Algen Biotechnologies, a privately held biotech company specializing in advanced CRISPR gene modulation and AI-driven drug discovery, has announced a multi-target partnership with AstraZeneca Plc ...

Exclusive collaboration and license agreement for the development and global commercialization of Arbor’s clinical-stage gene editing program, ABO-101 for primary hyperoxaluria type 1 (PH1) ...

A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin amyloidosis with polyneuropathy. Polyneuropathy stages and disability scores were ...

One of these players is a pharma giant trading for a dirt-cheap price today. The second stock here is a biotech company that’s recently proven the strength of its game-changing technology. 10 stocks ...

One of these players is a pharma giant trading for a dirt-cheap price today. The second stock here is a biotech company that’s recently proven the strength of its game-changing technology. These ...

MB-111 is a potential first-in-class, single-dose in vivo CRISPR gene editing therapy for persistent chylomicronemia Oral presentation highlights safe, robust, and durable reduction of apoC-III and ...

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...

A key feature is the ability to seamlessly move from mobile to desktop editing (currently in beta) (Image credit: Adobe) I attended an online briefing, where Adobe senior experience designer lead, ...